SymBiosis Capital Partners, LLC
Top Portfolio Positions
5 positions ·
$52,768,253 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| EVMN |
Evommune, Inc.
Healthcare
|
1,280,778 | $29,445,086 | 55.80% | |
| IVA |
Inventiva S.A.
Healthcare
|
2,354,000 | $13,064,700 | 24.76% | |
| WVE |
Wave Life Sciences Ltd.
Healthcare
|
750,000 | $5,437,500 | 10.30% | |
| RANI |
Rani Therapeutics Holdings, Inc.
Healthcare
|
3,667,585 | $2,695,674 | 5.11% | |
| CLNN |
Clene Inc.
Consumer Defensive
|
431,094 | $2,125,293 | 4.03% |
Portfolio Trend
2 quarters · across all stocks
Holdings in RANI
Shares Held
Position Value (USD)
2 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,695,674 | 3,667,585 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $8,505,000 | 6,300,000 | Shares | Sole | 2026-02-12 | |
| No 13F history on record for this holder in this stock. | ||||||